Pharming Group (PHARM)

[plumo]

Pharming To Present At Roth Growth Conference On March 12, 2012

Leiden, The Netherlands, March 8, 2012. Biotech company Pharming Group NV (“Pharming” or “the Company”) (NYSE Euronext: PHARM) today announced that Sijmen de Vries, Chief Executive Officer, will present at the following investment conference:


Roth Capital Partners 24th Annual Growth Stock Conference on Monday, March 12, 2012, at 3:00 p.m. pacific time (midnight Central European Time) in Dana Point, California, US.

A webcasts of this presentation will be available during the event at the ?Investor Relations’ section of www.pharming.com and will be archived and available on the website for 14 days.

About Roth Capital Partners Annual Growth Stock Conference
ROTH’s annual three-day conference brings together executives from over 400 growth companies and 1,000+ investors fro m the buy side. The event is designed to provide investors with a unique opportunity to gain insight into small and mid-cap growth companies across a variety of sectors, including healthcare. ROTH combines company presentations, Q&A sessions, expert panels and management one-on-one meetings to provide institutional clients with extensive interaction with senior management to gain in-depth insights into each company